Metabolomics Services Market in North America report 2028 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Metabolomics Services Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Metabolomics Services Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Rising focus on personalized medicine.
5.1.3 Increased funding for research and development.
5.1.4 Growing demand for disease biomarker discovery.

5.2 Market Opportunities

5.2.1
5.2.2 Development of integrated data analysis platforms.
5.2.3 Expansion into agricultural and environmental applications.
5.2.4 Collaborations with pharmaceutical companies for insights.

5.3 Future Trends

5.3.1
5.3.2 Increased use of AI for data interpretation.
5.3.3 Focus on non-invasive metabolomics techniques.
5.3.4 Growth of personalized nutrition services.

5.4 Impact of Drivers and Restraints

6. North America Metabolomics Services Market Regional Analysis

6.1 North America Metabolomics Services Market Overview

6.2 North America Metabolomics Services Market Revenue 2019-2028 (US$ Million)

6.3 North America Metabolomics Services Market Forecast Analysis

7. North America Metabolomics Services Market Analysis – by Service Type

7.1 Targeted Metabolomics Service and Untargeted Metabolomics Service

7.1.1 Overview
7.1.2 Targeted Metabolomics Service and Untargeted Metabolomics Service: North America Metabolomics Services Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Metabolomics Services Market Analysis – by Application

8.1 Pharmaceutical and Biotechnology Industry

8.1.1 Overview
8.1.2 Pharmaceutical and Biotechnology Industry: North America Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Agritech

8.2.1 Overview
8.2.2 Agritech: North America Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Environment

8.3.1 Overview
8.3.2 Environment : North America Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Metabolomics Services Market – North America Analysis

9.1 North America

9.1.1 North America Metabolomics Services Market Breakdown, by Key Country, 2022 and 2028 (%)
9.1.1.1 North America Metabolomics Services Market – Revenue and Forecast Analysis – by Country
9.1.1.1 US: North America Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 US: North America Metabolomics Services Market Breakdown, by Service Type
9.1.1.1.2 US: North America Metabolomics Services Market Breakdown, by Application

9.1.1.2 Canada: North America Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Canada: North America Metabolomics Services Market Breakdown, by Service Type
9.1.1.2.2 Canada: North America Metabolomics Services Market Breakdown, by Application

9.1.1.3 Mexico : North America Metabolomics Services Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 Mexico : North America Metabolomics Services Market Breakdown, by Service Type
9.1.1.3.2 Mexico : North America Metabolomics Services Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. North America Metabolomics Services Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 BASF SE

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 BGI

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 biocrates life sciences ag

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Chenomx Inc.

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Creative Proteomics

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Fred Hutchinson Cancer Research Center

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Metabolon, Inc.

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Molecular You

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 RTI International

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

12.10 TMIC

12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

12.11 West Coast Metabolomics Center

12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments

13. Appendix

13.1 About Business Market Insights